Publications

03-28 10:07
 
The effect of cangrelor and access site on ischaemic and bleeding events: insights from CHAMPION PHOENIX
03-28 10:07
 
Impact of intraprocedural stent thrombosis during percutaneous coronary intervention: insights from the CHAMPION PHOENIX Trial (Clinical Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subjects Who Require Percutaneous Coronary Intervention)
03-28 10:07
 
Consistent Reduction in Periprocedural Myocardial Infarction With Cangrelor as Assessed by Multiple Definitions: Findings From CHAMPION PHOENIX (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition)
03-28 10:07
 
Variation in Patient Profiles and Outcomes in US and Non-US Subgroups of the Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION) PHOENIX Trial
03-28 10:07
 
Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX Trial
03-28 10:07
 
Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention
03-28 10:07
 
Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial
03-28 10:07
 
Short- and long-term mortality following bleeding events in patients undergoing percutaneous coronary intervention: insights from four validated bleeding scales in the CHAMPION trials
03-28 10:07
 
Characteristics and outcomes of patients requiring bailout use of glycoprotein IIb/IIIa inhibitors for thrombotic complications of percutaneous coronary intervention: An analysis from the CHAMPION PHOENIX trial
03-28 10:07
 
Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX
03-28 10:07
 
Effect of Platelet Inhibition by Cangrelor Among Obese Patients Undergoing Coronary Stenting: Insights From CHAMPION
03-28 10:07
 
Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels, low bone mass, and physical frailty
03-28 10:07
 
Impulse oscillometry in COPD: identification of measurements related to airway obstruction, airway conductance and lung volumes
03-28 10:07
 
Testosterone and the aging male
03-28 10:07
 
Detection of changes in respiratory mechanics due to increasing degrees of airway obstruction in asthma by the forced oscillation technique
03-28 10:07
 
Clinical applications of forced oscillation techniques (FOT) in patients with bronchial asthma
03-28 10:07
 
Changes in respiratory mechanics with increasing degrees of airway obstruction in COPD: detection by forced oscillation technique
03-28 10:07
 
Evaluation of respiratory impedance in asthma and COPD by an impulse oscillation system
03-28 10:07
 
Evaluating the forced oscillation technique in the detection of early smoking-induced respiratory changes
03-28 10:07
 
High-resolution CT findings of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation
03-28 10:07
 
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report
03-28 10:07
 
From a Symptom-Based to a Mechanism-Based Pharmacotherapeutic Treatment in Complex Regional Pain Syndrome
03-28 10:07
 
Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists
03-28 10:07
 
Bronchiolitis obliterans following haematopoietic stem cell transplantation
03-28 10:07
 
Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation

Clinical Research News

Applying for a Paediatric investigation plan (PIP): review of the EMA guidelines
Considerations for the Use of Real-World Data and Real-World Evidence To Support Regulatory Decision-Making for Drug and Biological Products
Submission of comments on ICH E6 (R3) Guideline for Good Clinical Practice(GCP) - Step 2b 
ICH E6(R3) Good Clinical Practice guidance - Step 2 Public Consultation
The study of the new investigational drug for acute myeloid leukemia and myelodysplastic syndrome
Open Label study of entrectinib in ROS1 gene fusion-positive rare adult, paediatric and teenage/young adult cancers
Gasherbrum Bio, Inc is starting the study of GSBR-1290 drug in overweight or obese healthy adults

다가오는 임상 시험

Clinical Research Jobs

All jobs

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다